(Q46502283)

22 December 2017

title

Quality of life assessment during adjuvant and salvage chemotherapy for advance stage epithelial ovarian cancer (English)

1 reference

22 December 2017

1 reference

T Le

1

1 reference

22 December 2017

L Hopkins

series ordinal

2

1 reference

22 December 2017

M Fung Kee Fung

series ordinal

3

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

22 December 2017

published in

Gynecologic Oncology

1 reference

22 December 2017

volume

98

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

39-44

1 reference

22 December 2017

Psychological aspects of ovarian cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Determining the Relationship Between Toxicity and Quality of Life in an Ovarian Cancer Chemotherapy Clinical Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Quality of life in ovarian cancer patients receiving chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Reliability and validity of the functional assessment of cancer therapy-ovarian.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Attitudes to chemotherapy in patients with ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Treatment preferences in recurrent ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Risks and benefits of cisplatin in ovarian cancer. A quality-adjusted survival analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

Palliative therapy in advanced ovarian cancer: balancing patient expectations, quality of life and cost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.040

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2005.03.040

1 reference

22 December 2017

1 reference

22 December 2017